How to Diagnose DIC in Your Patient
Use the ISTH overt-DIC scoring system (≥5 points confirms diagnosis) in any patient with an appropriate trigger condition (sepsis, trauma, obstetric complication, malignancy, major surgery, or burns) who shows laboratory evidence of consumptive coagulopathy. 1, 2
Step 1: Confirm an Underlying Trigger Condition
DIC is never a primary disease—it always requires an underlying cause. 3 The most common triggers include:
- Sepsis (most common cause overall) 3
- Malignancy (especially pancreatic cancer, adenocarcinomas, acute promyelocytic leukemia, metastatic prostate cancer) 2, 3
- Trauma and major surgery 3
- Obstetric complications (placental abruption, amniotic fluid embolism, severe preeclampsia, acute fatty liver of pregnancy) 3, 4
- Burns 3
Without one of these triggers, reconsider the diagnosis. 3
Step 2: Apply the ISTH Overt-DIC Scoring System
The ISTH overt-DIC score is the validated gold standard for diagnosis. 1, 2 A score ≥5 points confirms overt DIC. 1, 2
Scoring Components:
Platelet count: 1
- <50 × 10⁹/L = 2 points
- ≥50 to <100 × 10⁹/L = 1 point
Fibrin-related markers (D-dimer/FDP): 1
- Strong increase = 3 points
- Moderate increase = 2 points
Prothrombin time prolongation: 1
- ≥6 seconds (PT ratio >1.4) = 2 points
- ≥3 to <6 seconds (PT ratio >1.2 to ≤1.4) = 1 point
Fibrinogen level: 2
- Decreased (typically <1 g/L in severe cases) = additional consideration
Step 3: Recognize Critical Diagnostic Pitfalls
A normal platelet count does NOT rule out DIC if the patient had initially elevated platelets. 2, 3 A ≥30% drop in platelet count is diagnostic of subclinical DIC even when absolute values remain in the normal range. 2, 3
PT and aPTT may be normal in cancer-associated DIC, especially subclinical forms. 3 Normal coagulation screens were found in approximately 50% of septic DIC cases. 3
Single laboratory values are less important than trends over time. 2 Dynamic monitoring over hours to days is more diagnostically valuable than isolated measurements. 2
Step 4: Identify the Clinical Phenotype
DIC presents in three distinct patterns that guide both diagnosis and management: 3
Procoagulant (Thrombotic) DIC:
- Associated conditions: Pancreatic cancer, adenocarcinomas 2, 3
- Clinical signs: Arterial ischemia, poor digital circulation, venous thromboembolism, microvascular thrombosis, cerebrovascular manifestations 2, 3
Hyperfibrinolytic (Bleeding) DIC:
- Associated conditions: Acute promyelocytic leukemia, metastatic prostate cancer 2, 3
- Clinical signs: Widespread bruising, bleeding from mucosal surfaces (gums, nose, GI tract), bleeding from venipuncture sites, CNS hemorrhage 2, 3
Subclinical DIC:
- Laboratory findings: ≥30% platelet drop, elevated D-dimer, mild coagulation factor consumption 2
- Clinical presentation: No obvious bleeding or thrombosis, only laboratory abnormalities 2
Step 5: Consider Additional Confirmatory Tests for Uncertain Cases
When the diagnosis remains unclear despite scoring: 3
- Factor VIII and von Willebrand factor: Low or declining levels confirm consumptive coagulopathy (distinguishes DIC from chronic liver disease, where these are normal or elevated) 3
- Antithrombin levels: Decreased in DIC due to consumption 1
Step 6: Differentiate DIC from Chronic Liver Disease
This is a common diagnostic challenge. Key distinguishing features: 3
| Feature | DIC | Chronic Liver Disease |
|---|---|---|
| Underlying trigger required | Yes [3] | No [3] |
| Organ involvement | Multiorgan failure from disseminated thrombi [3] | Usually not multisystem [3] |
| Laboratory changes | Rapid (hours to days) [3] | Stable or slowly progressive [3] |
| Factor VIII/VWF | Low or declining [3] | Normal or elevated [3] |
Step 7: Establish Monitoring Frequency Based on Clinical Severity
Daily monitoring: Acute severe DIC with active bleeding or rapid clinical deterioration 2
Every 2-3 days: Stable ICU patients with diagnosed DIC 2
Weekly: Hospitalized patients with chronic DIC (e.g., cancer-associated) 2
Monthly: Outpatients with stable subclinical DIC 2
Key Laboratory Tests to Order
Essential initial panel: 5, 6, 7
- Complete blood count with platelet count
- Prothrombin time (PT)
- Activated partial thromboplastin time (aPTT)
- Fibrinogen level
- D-dimer or fibrin degradation products (FDP)
D-dimer is highly sensitive for DIC and indicates active fibrinolysis. 2 Elevated D-dimer combined with thrombocytopenia in the appropriate clinical context strongly suggests DIC. 2, 6, 7
Common Pitfall to Avoid
Do not wait for all laboratory values to be severely abnormal before diagnosing DIC. 1 Early recognition using the SIC (sepsis-induced coagulopathy) criteria may identify patients in the compensated phase who could benefit from earlier intervention. 1 The SIC criteria use platelet count, PT ratio, and SOFA score to identify earlier-stage coagulopathy in septic patients. 1